DCAF1
- [1]. Ahn J, et al. The Cullin-RING E3 ubiquitin ligase CRL4-DCAF1 complex dimerizes via a short helical region in DCAF1. Biochemistry. 2011 Mar 1;50(8):1359-67. [Content Brief]
- [2]. Zhang J, et al. DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway. J Exp Clin Cancer Res. 2024 May 6;43(1):136. [Content Brief]
- [3]. Guo Z, et al. DCAF1 controls T-cell function via p53-dependent and -independent mechanisms. Nat Commun. 2016 Jan 5;7:10307. [Content Brief]
- [4]. Li ASM, et al. Discovery of Nanomolar DCAF1 Small Molecule Ligands. J Med Chem. 2023 Apr 13;66(7):5041-5060. [Content Brief]
- [5]. Ahn J, et al. HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation. J Biol Chem. 2010 Nov 26;285(48):37333-41. [Content Brief]
- [6]. Gérard FC, et al. Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest. PLoS One. 2014 Feb 18;9(2):e89195. [Content Brief]
- [7]. Guo Z, et al. DCAF1 regulates Treg senescence via the ROS axis during immunological aging. J Clin Invest. 2020 Nov 2;130(11):5893-5908. [Content Brief]
- [8]. Tao Y, et al. Targeted Protein Degradation by Electrophilic PROTACs that Stereoselectively and Site-Specifically Engage DCAF1. J Am Chem Soc. 2022 Oct 12;144(40):18688-18699. [Content Brief]
- [9]. Schabla NM, et al. DCAF1 (VprBP): emerging physiological roles for a unique dual-service E3 ubiquitin ligase substrate receptor. J Mol Cell Biol. 2019 Sep 19;11(9):725-735. [Content Brief]
- [10]. Schröder M, et al. DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance. Nat Commun. 2024 Jan 4;15(1):275. [Content Brief]
- [11]. Le Rouzic E, et al. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle. 2007 Jan 15;6(2):182-8. [Content Brief]
- [12]. Mabanglo MF, et al. Crystal structures of DCAF1-PROTAC-WDR5 ternary complexes provide insight into DCAF1 substrate specificity. Nat Commun. 2024 Nov 23;15(1):10165. [Content Brief]
- [13]. Kimani SW, et al. Discovery of a Novel DCAF1 Ligand Using a Drug-Target Interaction Prediction Model: Generalizing Machine Learning to New Drug Targets. J Chem Inf Model. 2023 Jul 10;63(13):4070-4078. [Content Brief]
- [14]. Yu C, et al. CRL4-DCAF1 ubiquitin E3 ligase directs protein phosphatase 2A degradation to control oocyte meiotic maturation. Nat Commun. 2015 Aug 18;6:8017. [Content Brief]
- [15]. Hakata Y, et al. Interactions with DCAF1 and DDB1 in the CRL4 E3 ubiquitin ligase are required for Vpr-mediated G2 arrest. Virol J. 2014 Jun 9;11:108. [Content Brief]
- [16]. Maudet C, et al. HIV-1 Vpr induces the degradation of ZIP and sZIP, adaptors of the NuRD chromatin remodeling complex, by hijacking DCAF1/VprBP. PLoS One. 2013 Oct 8;8(10):e77320. [Content Brief]
- [17]. Colomer-Lahiguera S, et al. Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland. Support Care Cancer. 2023 Jun 22;31(7):410. [Content Brief]